What the guideline says about nutraceuticals
The 2024 EASL-EASD-EASO guideline states that nutraceuticals cannot be recommended for MASLD because evidence of effectiveness and safety is insufficient [1]. That is a clear boundary for a commercial food site.
We should not compensate for an image-generation delay or product gap by filling the catalogue with supplement guides, herbal protocols or detox recipes.
Sources for this section: [1] EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Coffee is not a medicine either
The same guideline notes observational associations between coffee consumption and liver outcomes. An association is not a reason to prescribe coffee as treatment, especially when tolerance, caffeine sensitivity and other health factors vary.
A normal coffee recipe can remain a food choice; it should not wear a therapeutic liver claim.
Sources for this section: [1] EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Alcohol needs clinical context
Current MASLD guidance discourages alcohol consumption and becomes stricter with more advanced fibrosis [1] [2]. Diagnosis and fibrosis stage are clinical matters, so a generic website cannot safely translate that into one personal alcohol allowance [3].
The simplest product-safe approach is not to build alcohol into the health promise and to direct readers with liver disease questions to their clinical guidance.
Sources for this section: [1] EASL–EASD–EASO Clinical Practice Guidelines on MASLD · [3] Diagnosis of NAFLD & NASH
Keep the positive offer practical
Rejecting detox marketing does not make the publication negative. It creates room for a stronger offer: ordinary enjoyable recipes built around fibre-rich plants, appropriate proteins, unsaturated fats and lower-sugar drink choices.
That is enough culinary work to do without pretending the book treats or stages liver disease.
Sources for this section: [1] EASL–EASD–EASO Clinical Practice Guidelines on MASLD · [2] AASLD Practice Guidance on the clinical assessment and management of NAFLD/MASLD
Food should stay food
Herbs, spices, tea and other ordinary foods can be used because they taste good and fit the recipe. They should not acquire a medicinal liver claim merely because a laboratory or observational study has examined one component.
Keeping culinary and therapeutic claims separate makes recipes more trustworthy and prevents normal ingredients from becoming vehicles for unsupported treatment marketing.
Sources for this section: [1] EASL–EASD–EASO Clinical Practice Guidelines on MASLD
Sources
- EASL–EASD–EASO Clinical Practice Guidelines on MASLD
European Association for the Study of the Liver, European Association for the Study of Diabetes, European Association for the Study of Obesity. Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease. 2024. Verified 1 Sept 2026. - AASLD Practice Guidance on the clinical assessment and management of NAFLD/MASLD
Rinella ME, Neuschwander-Tetri BA, Siddiqui MS, et al. AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease. Hepatology. 2023;77(5):1797-1835. Verified 1 Sept 2026. - Diagnosis of NAFLD & NASH
National Institute of Diabetes and Digestive and Kidney Diseases. Diagnosis of NAFLD & NASH (also referred to as MASLD/MASH). Verified 1 Sept 2026.